C41 - Peripheral Neuropathy II: Diabetic and Inherited Neuropathies

Event Time: Sunday April 22, 2018 1:00 pm to 3:00 pm
Topic(s): Neuromuscular and Clinical Neurophysiology (EMG)
Director(s): Michael Shy MD
Description: Peripheral neuropathies (PN) ultimately affect almost 10 percent of the population. New diagnostic and management options make rational therapies for PN increasingly possible. However, the high cost of certain diagnostic tests and therapies, along with the complexities involved in choosing which tests and treatments to initiate, complicate the management of patients with PN. Faculty will review approaches and management issues for patients with inherited neuropathies, as well as approaches and management issues for the various forms of diabetic neuropathy. This program complements C31: Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies and C56: Peripheral Neuropathy III: Genetic Testing and Next Generation Sequencing, but covers independent topics.
Completion Message: Participants should be able to determine whether a neuropathy is likely to be genetically based; identify the likely genetic causes of a genetic neuropathy; become familiar with current and future management approaches in different genetic causes of inherited neuropathy; identify the distinct forms of diabetic neuropathy; determine whether a neuropathy is likely to be related to diabetes; and obtain a rational, evidence-based approach to treating diabetic neuropathies.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses